Radx independent test assessment program for mpox lesion panel - validation center
Active Awarded Last action
- Contract number
- 75N92023F00002
- Awardee
-
Emory University UEI S352L5PJLMP8
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,186,787
Award facts
- Contract value 69% obligated
-
- $2,186,787.00 Current, with exercised options
- $3,186,787.00 Potential, with all options
- Completion date 94% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- B599 Special Studies/Analysis- Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Atlanta, GA 30322, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $2,186,787 |
About this award
Emory University, a private research institution located in Atlanta, Georgia, received a $3.2M firm fixed-price delivery order from the National Heart, Lung, and Blood Institute (NHLBI) on September 27, 2023, for the RADX Independent Test Assessment Program for Mpox Lesion Panel Validation Center. This contract, which carries no set-aside designation, tasks Emory with validating diagnostic test panels for mpox (monkeypox) as part of the federal government's broader RADX initiative to expand testing capacity and accelerate the development of diagnostic tools during public health emergencies. The work is scheduled for completion by December 31, 2026, and will be performed at Emory's Atlanta facility.
Emory University's selection reflects its established expertise in biomedical research, infectious disease studies, and clinical diagnostics. The university, which maintains tax-exempt status as a nonprofit educational institution, has demonstrated substantial capability in supporting federal health initiatives through previous contracts with the National Institutes of Health and other government agencies. This delivery order aligns with Emory's portfolio of federal work in medical research and testing validation, leveraging its research infrastructure and specialized scientific capabilities to advance the government's pandemic preparedness and response objectives.
Quick answers
Who was awarded contract 75N92023F00002?
75N92023F00002 was awarded to Emory University by National Heart Lung and Blood Institute (National Institutes of Health) on September 27, 2023.
How much is contract 75N92023F00002 worth?
The government has obligated $2,186,787 on 75N92023F00002. Its potential value, with all options, is $3,186,787.
Is contract 75N92023F00002 an order under another contract?
Yes. 75N92023F00002 is a delivery order under 75N92022D00015, an indefinite delivery contract.
Was contract 75N92023F00002 competed?
The extent of competition for 75N92023F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award